H3 BIOMEDICINE Trademark

Trademark Overview

On Wednesday, January 26, 2011, a trademark application was filed for H3 BIOMEDICINE with the United States Patent and Trademark Office. The USPTO has given the H3 BIOMEDICINE trademark a serial number of 85226233. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Monday, August 14, 2023. This trademark is owned by H3 Biomedicine Inc.. The H3 BIOMEDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development of pharmaceuticals for the treatment of cancer
h3 biomedicine

General Information

Serial Number85226233
Word MarkH3 BIOMEDICINE
Filing DateWednesday, January 26, 2011
Status711 - CANCELLED - SECTION 7
Status DateMonday, August 14, 2023
Registration Number4238304
Registration DateTuesday, November 6, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2012

Trademark Statements

Pseudo MarkH THREE BIO MEDICINE
Disclaimer with Predetermined Text"BIOMEDICINE"
Goods and ServicesPharmaceutical research and development of pharmaceuticals for the treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateMonday, August 14, 2023
Primary Code042
First Use Anywhere DateThursday, January 27, 2011
First Use In Commerce DateThursday, January 27, 2011

Trademark Owner History

Party NameEISAI R&D MANAGEMENT CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTOKYO 112-8088
JP
Party NameH3 Biomedicine Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameH3 Biomedicine Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameH3 Biomedicine Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodcliff Lake, NJ 10520

Trademark Events

Event DateEvent Description
Tuesday, August 15, 2023NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, August 14, 2023CANCELLED SECTION 7-TOTAL
Wednesday, January 25, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Sunday, August 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 25, 2023TEAS SECTION 7 SURRENDER RECEIVED
Monday, October 3, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, November 6, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 12, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 20, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 7, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 23, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, November 6, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 6, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, October 2, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 1, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 28, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 6, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 30, 2012USE AMENDMENT FILED
Thursday, September 6, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 30, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, March 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 3, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 21, 2011ASSIGNED TO LIE
Friday, October 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 28, 2011EXAMINER'S AMENDMENT ENTERED
Friday, October 28, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 28, 2011EXAMINERS AMENDMENT E-MAILED
Friday, October 28, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, October 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 2, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 2, 2011NON-FINAL ACTION E-MAILED
Monday, May 2, 2011NON-FINAL ACTION WRITTEN
Monday, April 25, 2011ASSIGNED TO EXAMINER
Tuesday, February 1, 2011NOTICE OF PSEUDO MARK MAILED
Monday, January 31, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 29, 2011NEW APPLICATION ENTERED

Related Keywords

biomedicine treatment cancer pharmaceuticals development research pharmaceutical